ClinicalTrials.gg
CompletedNCT07729306Ar-KJOCUpdated Jul 27, 2026

TRANSLATION, ADAPTATION, VALIDATION AND RELIABILITY OF ARABIC VERSION OF KERLAN-JOBE ORTHOPAEDIC CLINIC SHOULDER AND ELBOW SCORE IN EGYPTIAN SYMPTOMATIC OVERHEAD ATHLETES

An observational study in Shoulder and Elbow Injury, sponsored by Ziad Mohamed Mohamed Abdalla Haroun. Completed at 1 site in Egypt. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by Ziad Mohamed Mohamed Abdalla Haroun · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 45 Years
Sex
All
01

Study summary

PURPOSE:

To perform a cross-cultural adaption of the KJOC Shoulder and Elbow score into the Arabic language, then to test its validity and reliability.

BACKGROUND:

Shoulder and elbow injuries are highly prevalent among overhead and throwing athletes, particularly in sports such as baseball, handball, volleyball, and tennis throwing. Accurate assessment of upper extremity function in this athletic population is essential for injury prevention, clinical decision-making, and monitoring return-to-sport outcomes.

The Kerlan-Jobe Orthopaedic Clinic (KJOC) Shoulder and Elbow Score is a sport-specific, patient-reported outcome measure (PROM) developed to evaluate functional performance, pain, and sport-related limitations in overhead athletes. It has been widely used and validated in several languages including Spanish, Germany, Japanese, and Greek; however, no validated Arabic version is currently available.

Simple literal translation is insufficient for patient-reported outcome measures. Instead, a structured process of translation, cultural adaptation, and comprehensive psychometric validation is required to ensure linguistic accuracy, conceptual equivalence, cultural relevance, and measurement reliability for Arabic-speaking athletes.

HYPOTHESES:

The study hypothesizes that the Arabic version of the KJOC shoulder and elbow score will demonstrate strong validity and reliability as an assessment tool for evaluating upper extremity function in symptomatic Arabic-speaking overhead athletes.

RESEARCH QUESTION:

Is the adapted Arabic version of the KJOC Shoulder and Elbow score valid and reliable for assessing upper extremity function in Egyptian symptomatic overhead athletes?

Read the detailed description

This study will use a Descriptive, Methodological Design (Cross-Cultural Adaptation).

Description of Research Methodology: The study will follow standard international guidelines for cross-cultural adaptation (e.g., Beaton et al.).

PHASE 1: CROSS-CULTURAL ADAPTATION

The process includes five stages:

1) translation, 2) synthesis of translations, 3) back-translation to the original language, 4) committee analysis, and 5) pre-testing.

Forward Translation: Two independent translators (one medical, one naive) translate English to Arabic.

Synthesis: Merging translations into one Arabic version. Backward Translation: Translating the Arabic version back to English by two native translators.

Expert Committee Review: Reviewing all reports to reach a pre-final version. Pre-testing (Cognitive Debriefing): Testing the pre-final version on a pilot sample of athletes to ensure clarity and cultural relevance.

PHASE 2: VALIDATION AND RELIABILITY TESTING By comparing the KJOC-Arabic's concurrent validity to the Arabic DASH questionnaire and using statistical and discriminant analyses to determine its construct validity, the validity of the test will be thoroughly evaluated. Participants will complete the questionnaire twice over the course of one to two weeks in order to assess test-retest reliability. An Intraclass Correlation Coefficient (ICC) of more than 0.80 is the target. Lastly, the Cronbach's alpha-coefficient of the translated assessment tool will be determined to assess its internal consistency.

02

Conditions studied

  • Shoulder and Elbow Injury

Keywords

  • sports injury
  • shoulder pain
  • elbow pain
03

In context

Elbow Injuries

21 studies on the registry are indexed under Elbow Injuries; 6 are open to participants now.

Browse Elbow Injuries studies →

Lead sponsor

This is the only study on the registry with Ziad Mohamed Mohamed Abdalla Haroun as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

This study will be conducted on 100 symptomatic Egyptian overhead athletes. They will be screened for inclusion and exclusion criteria.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female symptomatic athletes who participates in overhead sports (badminton, water polo, basketball, baseball, softball, handball, volleyball, or tennis) at least twice a week (Paraskevopoulos et al., 2024).
  • Age ranges from 18 to 45 years old (Schulz et al., 2022).
  • Non illiterate native Arabic speakers

Exclusion criteria

Exclusion criteria:

  • History of upper limb injury or any other injury that prevents the athlete from actively participating in their sport (Sukanen et al., 2022).
  • History of recent upper limb trauma, neuropathic pain, or surgery (Sasagawa et al., 2024).
  • Asymptomatic athletes who participate in overhead sports
  • Occurrence of a new injury during the study's reliability assessment interval (Sedighimehr, 2020).
  • Surgery that prevents full sports participation
  • Arabic speakers who are not native speakers.
  • Being illiterate or unable to read Arabic.
  • Visual or cognitive difficulties that make it difficult to read the questionnaire or take part in the interview.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
100 participants (actual)
Target follow-up
1 Week
Patient registry
Yes

Interventions

  • Diagnostic testQuestionnaire and Physical Exam

    This study will use a Descriptive, Methodological Design (Cross-Cultural Adaptation). Description of Research Methodology: The study will follow standard international guidelines for cross-cultural adaptation (e.g., Beaton et al.). PHASE 1: CROSS-CULTURAL ADAPTATION The process includes five stages: 1\) translation, 2) synthesis of translations, 3) back-translation to the original language, 4) committee analysis, and 5) pre-testing. Forward Translation: Two independent translators (one medical, one naive) translate English to Arabic. Synthesis: Merging translations into one Arabic version. Backward Translation: Translating the Arabic version back to English by two native translators. Expert Committee Review: Reviewing all reports to reach a pre-final version. Pre-testing (Cognitive Debriefing): Testing the pre-final version on a pilot sample of athletes to ensure clarity and cultural relevance. PHASE 2: VALIDATION AND RELIABILITY TESTING By comparing the KJOC-Arabic's concurrent valid

06

What researchers measure

Primary outcomes

  1. The KJOC Shoulder and Elbow score

    The KJOC Shoulder and Elbow score is used to evaluate the functional status of athletes with shoulder and elbow disorders (Appendix II) (Silva et al., 2024). The KJOC is a 10-item visual analogue scale questionnaire given to patients; lower scores indicate a lower function or performance level, while higher scores indicate a greater function or performance level. The total score, which ranges from 0 to 100 points, is determined by adding together each individual item (Alberta et al., 2010). The KJOC score is the most sensitive for distinguishing minor differences in a throwing athlete's performance (Domb et al., 2010). KJOC is valid (Spearman: KJOC and DASH sports module =- 0.8036, KJOC and DASH =-0.6933) and reliable (Cronbach alpha of 0.9, indicating a high level of inter-item reliability (Domb et al., 2010), ICC= 0.802 (Erickson et al., 2018)).

    Time frame: 4 weeks

  2. Arabic version of DASH

    The DASH is a 30-item self-report survey with 5-point Likert scales. The range of scores is 0 (no disability) to 100 (the most severe disability). It is a general non-specific PROM helpful for individuals with any upper limb musculoskeletal condition (Hudak et al., 1996). Items include 21 questions evaluating particular physical tasks (e.g., using a knife or turning a key), 5 items evaluating symptoms (e.g., pain, tingling), and 4 questions evaluating social functions (e.g., sleep and confidence) (David et al., 2022). DASH has been transculturally adapted to Arabic language (Alotaibi, 2010). The DASH-Arabic is a valid, responsive, and dependable upper extremity outcome measure (Alotaibi et al., 2016), (Appendix IV).

    Time frame: 4 weeks

07

Study locations

1 site
  • Cairo University
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2026 to primary completion in Jul 2026, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2026
First posted
Jul 27, 2026
StartActual
Jun 1, 2026
Primary completionActual
Jul 1, 2026
CompletionActual
Jul 1, 2026
Last update
Jul 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07729306
Lead sponsor
Ziad Mohamed Mohamed Abdalla Haroun
Collaborators
Cairo University
Responsible party
Ziad Mohamed Mohamed Abdalla Haroun (physiotherapist, Cairo University) — Sponsor-investigator
First posted
Jul 27, 2026
Start date
Jun 1, 2026
Primary completion
Jul 1, 2026
Completion
Jul 1, 2026
Last update
Jul 27, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion